Neurobehavioral effects of levetiracetam in brain tumor related epilepsy. Academic Article

abstract

• The neurobehavioral profile of anti-epileptic drugs (AEDs) has been a recurrent research topic in the scientific literature. As pharmacological treatments for epilepsy continue to evolve, there is a general consensus that newer AEDs have less detrimental side effects in comparison to their older counterparts. Among newer AEDs and epilepsy patients, potential risk for neurobehavioral changes has been reported with levetiracetam (LEV). Conversely, limited data exists regarding the manifestation of this symptomatology in a subgroup of epilepsy patients with brain tumors. The current paper reviews the literature regarding the neurobehavioral profile of LEV in brain tumor related epilepsy and suggestions for future research will be discussed.

authors

• Kirmani, MD, FAAN, FAES, Batool

published proceedings

• Front Neurol

altmetric score

• 0.5

author list (cited authors)

• Bernett, A., Phenis, R., Fonkem, E., Aceves, J., Kirmani, B., & Cruz-Laureano, D.

citation count

• 10

complete list of authors

• Bernett, Abigail||Phenis, Richard||Fonkem, Ekokobe||Aceves, Jose||Kirmani, Batool||Cruz-Laureano, Daniel

publication date

• January 2013

publisher

• Frontiers  Publisher

published in

• Frontiers in Neurology  Journal

keywords

• Brain Tumors
• Levetiracetam
• Neurobehavioral
• Seizures

PubMed Central ID

• 23885253

Digital Object Identifier (DOI)

• 10.3389/fneur.2013.00099

URI

• https://hdl.handle.net/1969.1/179293

start page

• 99

volume

• 4

URL

• http://dx.doi.org/10.3389/fneur.2013.00099